參考文獻/References:
[1] TAN B,LI W,ZENG P,et al.Epidemiological study based on China osteonecrosis of the femoral head database[J].Orthop Surg,2021,13(1):153-160.
[2] FERGUSON R J,PALMER A J,TAYLOR A,et al.Hip replacement[J].Lancet(London,England), 2018, 392(10158): 1662-1671.
[3] 趙德偉,程亮亮.國內(nèi)股骨頭壞死保留髖關(guān)節(jié)手術(shù)治療的十年回顧[J].中華骨科雜志,2017,37(3):183-192.
[4] SOHATEE M A,ALI M,KHANDUJA V,et al.Does hip preservation surgery prevent arthroplasty?Quantifying the rate of conversion to arthroplasty following hip preservation surgery[J].J Hip Preserv Surg,2020,7(2):168-182.
[5] 何偉.如何把握股骨頭壞死患者的保髖治療時機[J].中國骨與關(guān)節(jié)雜志,2016,5(2):82-86.
[6] BASAL O,ATAY T,CIRIS IM,et al.Epidermal growth factor(EGF)promotes bone healing in surgically induced osteonecrosis of the femoral head(ONFH)[J].Bosn J Basic Med Sci,2018,18(4):352-360.
[7] PALEKAR G.Hip preservation with autologous osteoblast cell-based treatment in osteonecrosis of the femoral head[J].Orthopedics,2021,44(2):e183-e189.
[8] 周樹龍.基于CT雙壁理論探討股骨頭壞死ARCOⅡ期保髖方式的適應(yīng)癥[D].南寧:廣西中醫(yī)藥大學,2022.
[9] 陸舜,林天燁,何敏聰,等.基于前外側(cè)保留角預(yù)測股骨頭壞死塌陷的有限元分析[J].中國修復(fù)重建外科雜志,2023,37(11):1394-1402.
[10] 何敏聰,何曉銘,林天燁,等.基于CT壞死區(qū)重建的股骨頭壞死側(cè)位分型及其臨床驗證[J].中國修復(fù)重建外科雜志,2023,37(4):423-430.
[11] 魏秋實,何曉銘,何偉,等.非手術(shù)保髖治療ARCOⅡ期股骨頭壞死的臨床療效及影響因素分析[J].中華骨與關(guān)節(jié)外科雜志,2022,15(6):424-430.
[12] MOTOMURA G,YAMAMOTO T,YAMAGUCHI R,et al.Morphological analysis of collapsed regions in osteonecrosis of the femoral head [J].J Bone Joint Surg Br,2011,93(2):184-187.
[13] YOSHIDA H,FAUST A,WILCKENS J,et al.Three-dimensional dynamic hip contact area and pressure distribution during activities of daily living[J].J Biomech,2006,39(11):1996-2004.
[14] GENDA E,IWASAKI N,LI G,et al.Normal hip joint contact pressure distribution in single-leg standing-effect of gender and anatomic parameters[J].J Biomech,2001,34(7):895-905.
[15] 中國微循環(huán)學會骨微循環(huán)專業(yè)委員會.股骨頭壞死臨床診療技術(shù)專家共識(2022年)[J].中國修復(fù)重建外科雜志,2022,36(11):1319-1326.
[16] 中國微循環(huán)學會骨微循環(huán)專業(yè)委員會.股骨頭壞死臨床藥物防治專家共識(2022年)[J].中國骨傷,2023,36(8):724-730.
[17] 田照,曾平,徐勇,等.曾平教授從“補腎活血”角度運用補腎通蝕丸治療股骨頭缺血性壞死經(jīng)驗[J].時珍國醫(yī)國藥,2022,33(3):717-719.
[18] 曾平,賴崇榮,李金溢,等.圍塌陷期股骨頭壞死的聯(lián)合治療:髓芯減壓、自體髂骨打壓植骨、異體腓骨植入與中藥[J].中國組織工程研究,2018,22(36):5746-5752.
[19] 馮程欽,曾平,劉金富,等.曾平教授治療小兒股骨頭壞死的學術(shù)思想和臨床經(jīng)驗總結(jié)[J].中國醫(yī)藥導(dǎo)報,2021,18(15):17-20.
[20] SUGANO N,ATSUMI T,OHZONO K,et al.The 2001 revised criteria for diagnosis,classification,and staging of idiopathic osteonecrosis of the femoral head[J].J Orthop Sci,2002,7(5):601-605.
[21] 龐智暉,何偉,張慶文,等.中藥輔助改良減壓植骨內(nèi)穩(wěn)定術(shù)治療圍塌陷期激素性股骨頭壞死[J].中國中醫(yī)骨傷科雜志,2009,17(1):30-33.
[22] WEI Q S,HONG G J,YUAN Y J,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:A prospective study[J].J Orthop Translat,2018,18:65-73.
[23] HUANG Z,FU F,YE H,et al.Chinese herbal Huo-Gu formula for the treatment of steroid-associated osteonecrosis of femoral head:A 14-year follow-up of convalescent SARS patients[J].J Orthop Translat,2020,23:122-131.
[24] 何曉銘,魏秋實,何偉,等.非創(chuàng)傷性股骨頭壞死患者的中醫(yī)證候及疼痛特點[J].中華中醫(yī)藥雜志,2020,35(7):3656-3659.
[25] 陳財,曾平,劉金富,等.酒精性股骨頭壞死的發(fā)病機制及其氣滯血瘀型中醫(yī)藥治療的研究進展[J].廣西醫(yī)學,2022,44(4):438-442.
[26] 黃建烽,何海軍.從酒傷理論論治酒精性股骨頭壞死[J].中醫(yī)正骨,2022,34(9):69-72.
[27] 李盛華,陳彥同,周明旺,等.非創(chuàng)傷性股骨頭壞死從“痰”論治探微[J].中國中醫(yī)藥信息雜志,2019,26(9):4-7.
[28] 劉楠,王軍威,劉德玉.劉德玉“四辨”論治非創(chuàng)傷性股骨頭壞死的中醫(yī)藥保髖治療經(jīng)驗[J].長春中醫(yī)藥大學學報,2023,39(10):1095-1100.
[29] 劉子嘉,李瑩,崔朋濤,等.補腎活血方治療股骨頭壞死肝腎虧虛證的臨床療效及對骨代謝指標PINP、β-CTX的影響[J].中國實驗方劑學雜志,2024,30(3):81-89.
[30] 梅其杰,徐文飛,段戡,等.十一方藥酒涂擦結(jié)合艾瑞昔布片治療膝骨關(guān)節(jié)炎的臨床療效觀察[J].中國中醫(yī)骨傷科雜志,2021,29(10):43-46.
[31] HUA K C,YANG X G,FENG J T,et al.The efficacy and safety of core decompression for the treatment of femoral head necrosis:a systematic review and meta-analysis[J].J Orthop Surg Res,2019,14(1):306.
[32] WU H,CHENG K,TONG L,et al.Knowledge structure and emerging trends on osteonecrosis of the femoral head: a bibliometric and visualized study[J].J Orthop Surg Res,2022,17(1):194.
[33] MONT M A,SALEM H S,PIUZZI N S,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?:a 5-year update[J].J Bone Joint Surg Am,2020,102(12):1084-1099.
[34] GAUTIER E,GANZ K,KRÜGEL N,et al.Anatomy of the medial femoral circumflex artery and its surgical implications[J].J Bone Joint Surg Br,2000,82(5):679-683.
[35] 雷志強,曾平,羅鈞.髖關(guān)節(jié)外科脫位技術(shù)治療股骨頭壞死的研究進展[J].廣西醫(yī)學,2020,42(4):474-476.
[36] 杜敏東,劉雄,秦剛,等.髖關(guān)節(jié)外科脫位頭頸開窗打壓植骨術(shù)聯(lián)合活血補腎方治療中晚期腎虛血瘀型股骨頭壞死的臨床療效[J].廣西醫(yī)學,2019,41(22):2821-2824.
[37] 盛東,宋瓊,張慶文,等.經(jīng)髖關(guān)節(jié)外科脫位入路自體髂骨瓣打壓植骨治療中青年ARCOⅡ、Ⅲ期股骨頭缺血性壞死[J].中國骨與關(guān)節(jié)損傷雜志,2021,36(2):153-155.
[38] 魏秋實,龐鳳祥,陳嘵俊,等.經(jīng)髖關(guān)節(jié)外科脫位打壓植骨支撐術(shù)治療ARCO Ⅲ期股骨頭壞死的臨床療效分析[J].中華損傷與修復(fù)雜志(電子版),2020,15(2):90-95.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.